IMPORTANCE Vigorous exercise (particularly endurance sports) might increase the risk of atrial fibrillation (AF), but there is variability in the reported frequency of this condition among elite athletes. The underlying pathophysiologic source remains unclear.
M oderate-intensity physical exercise decreases the risk of cardiovascular disease and cardiac events through various mechanisms, including cardioprotection against ischemia 1 and a decreased risk of malignant arrhythmias. 2 However, the potential benefits of very high exercise loads are more questionable, with strenuous exercise, particularly endurance sports, potentially increasing the risk of atrial fibrillation (AF). 3, 4 There is, nevertheless, variability in the reported frequency of AF among athletes. 5 The pathophysiologic factors associated with this condition remain unclear, with training-induced left atrial (LA) remodeling thought of as a potential contributor. 5 We therefore studied AF incidence in a large cohort of elite athletes and its association with potential risk factors, such as atrial dimension.
Methods
We followed a single-center, retrospective, observational cohort design to determine AF incidence in all Spanish athletes who were referred for 1 or more evaluation (including M-mode and 2-dimensional echocardiography) in the Department of Cardiology, Sports Medicine Center, Spanish Sports Health Protection Agency, Madrid, Spain, from January 1, 1997, to December 31, 2017, and meeting the criteria of being on national teams and competing in major international events. All athletes with AF were evaluated on occurrence of this condition. The protocol was approved by the local ethics committee (Universidad Europea Miguel de Cervantes-Comité de Ética de la Investigación) and conformed to the Declaration of Helsinki. 6 The participants provided oral consent.
We also performed a cross-sectional comparison of the characteristics (including echocardiography) of athletes showing or not showing AF. To this end, we used the data obtained on AF diagnosis (AF athletes) and those corresponding to the last available assessment (non-AF athletes). We performed a within-participant longitudinal comparison of baseline echocardiographic characteristics and those corresponding to AF occurrence in athletes in the AF group with complete data from 2 or more serial evaluations.
Diagnosis of AF was based on resting and/or exercise electrocardiogram, and/or 24-hour Holter monitoring. Regarding the latter, to screen for potential AF cases, all athletes with 1 or more potentially suspicious cardiac signs (resting heart rate <40 beats/min, frequent extrasystoles in resting/exercise electrocardiogram) underwent 24-hour Holter monitoring during the study period (n = 1505 assessments). All echocardiography evaluations (Philips Sonos 7500 system; Advanced Diagnostics) were conducted to determine right superoinferior diameter (RA.Sid), LA.SId, LA anteroposterior diameter (LA.APd), and sphericity index (LA.APd/LA.SId ×100). Cardiologists responsible for echocardiographic assessment were not blinded to the condition (AF or no AF) of the athletes.
Statistical Analysis
Fisher exact and unpaired, 2-tailed t tests for categorical and continuous variables, respectively, were used to compare the group of athletes with AF and their non-AF peers. A nonparametric Mann-Whitney test was used to compare baseline echocardiography data and those obtained on AF occurrence in athletes showing AF and having complete echocardiography data from 2 or more evaluations. Logistic regression analyses (univariate and multivariate, stepwise forward) were performed to determine the association between risk of AF and potential contributing factors (age, years of competition, participation in endurance sports, atrial dimensions). Receiver operating characteristic curves were calculated to determine potential cutoff points for factors associated with AF risk. The level of statistical significance was set at P < .05, and all analyses were performed with the Stata Statistical Software Package for Macintosh, version 13 (StataCorp).
Results
The cohort comprised 6813 athletes (mean [SD] age, 22 [7] years, with a mean [SD] time of 8 [5] years of competition, and included 2385 [35.0%] women) participating in most sports disciplines, including 28% endurance (eg, running, triathlons), 47% mixed (eg, team sports), and 25% power/sprint sports (eg, sprint/throwing/jumping track and field events, weightlifting) ( Table 1 ). The mean (SD) total number of evaluations per athlete was 3 (3), with 4306 (63.2%) individuals in the cohort undergoing 2 or more complete evaluations. The mean (SD) number of evaluations in the AF group was 3 (1), with 9 athletes evaluated only once.
Only 21 athletes (1 woman), participating in distance running, basketball (n = 5 each), canoeing (n = 3), triathlon, soccer (n = 2 each), and rowing, mountaineering, golf, or track and field sprint events (n = 1 each), had AF (ie, paroxysmal [n = 18], persistent [n = 1], or long-standing persistent [n = 2]) during the 20-year study period. Diagnosis was based on resting (n = 13) and/or exercise electrocardiogram (n = 5), and/or 24-hour Holter monitoring (n = 15). Except for 1 athlete, all of the cases were symptomatic, usually in the form of palpitations at rest or after exertion with or without reported fatigue or performance decrements. One case was not attributable to sports practice (thyroiditis related) and no case has led to major clinical consequences.
Athletes with reported AF showed higher (all P < .001) values than their non-AF peers for male sex (100% vs 65%, respectively), mean (SD) age (38 [13] vs 22 [6] years), years of
Key Points
Question What is the incidence of atrial fibrillation in a large cohort of elite athletes and its association with potential risk factors?
Findings In this 20-year study of 6813 athletes (35.0% women), with most sports disciplines represented, only 21 athletes (1 woman) had atrial fibrillation. Increasing values of age, years of competition, and left atrial anteroposterior diameter were the main factors associated with higher atrial fibrillation risk.
Meaning
The incidence of atrial fibrillation is low among young elite athletes, but potential contributors (eg, atrial dimensions) need to be monitored.
Incidence of Atrial Fibrillation in Elite Athletes
Brief (7) 125 (9)/64 (7) 175 (11) 69 ( (7) 176 (10) 69 (13) Table 2 . Increasing values of age, years of competition (athletes competing in masters categories), and LA.APd were associated with higher AF risk in multivariate analysis. In athletes in the AF group with 2 or more evaluations (n = 12), no significant differences were found between baseline assessment and the assessment corresponding to AF occurrence for mean (SD) values of RA.SId (58 [10] vs 61 [7] mm, respectively, P = .07), LA.SId (57 [6] vs 59 [7] mm, P = .45), LA.APd (43 [6] vs 45 [9] mm, P = .30), and sphericity index (77% [13%] vs 77% [12%], P = .85).
Discussion
The incidence of AF among young Spanish elite athletes was low (0.3%) as expected in young people, and nearly identical to that reported in previous research with young elite athletes (ie, 0.3% in Italian athletes aged 24 years on average). 7 The fact that the reported prevalence of AF among athletes is variable, ranging from 0.3% to 12.8%, likely reflects methodologic biases, such as differences between studies in the participants' age (which was lower in our participants than in most research in the field), training status, or sports specialty. 8 Increased arterial pressure during exercise, together with atrial wall stretching, such as that potentially induced by longterm exposure to strenuous endurance exercise, might lead to microtrauma, inflammation, and fibrosis, which are arrhythmogenic. 5 Regarding LA enlargement, our data are in overall agreement with those from a healthy, nonathletic Spanish population, 9 suggesting that LA remodeling toward sphericity (ie, greater enlargement of the anteroposterior relative to the longitudinal diameter) is associated with an increased AF risk. In athletes, LA enlargement might increase proportionally with lifetime training hours or within competition level, 5 with previous research 7 showing that approximately 20% of young competitive athletes (mean age, 24 years) have an LA.APd greater than 40 mm vs 10% in the present study. In this regard, although increased LA size in athletes is overall considered a physiologic, nonpathologic cardiac adaptation, 5 our data suggest that follow-up of LA dimensions might be useful in young athletes with high LA.APd values.
Limitations and Strengths
Our findings are limited by the retrospective design and the population studied, which included only athletes of Spanish nationality. Further research is needed with 3-dimensional cardiac imaging techniques, allowing for better geometric LA characterization. In addition, we might have underestimated AF incidence by missing some silent cases or those of athletes unwilling to recognize their condition, despite relying on several diagnostic methods (resting and exercise electrocardiography and 24-Holter monitoring). In this regard, the best method of AF screening remains a matter of debate, with AF being more infrequent, especially in young adults, and difficult to identify than other cardiovascular diseases (eg, hypertension) where screening is routinely applied. 10 Furthermore, given the often paroxysmal nature of the arrhythmia, especially in otherwise healthy athletes, such as those studied herein, any screening method that uses a single rhythm snapshot, irrespective of the technique used, is unlikely to detect individuals with AF types other than persistent or high-burden paroxysmal AF.
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Strengths of our study are the large elite athletes cohort, including many women, who have been rarely studied in research on sports-related AF and numerous sports disciplines, and identification of cutoff values for potential contributors to AF risk (notably, LA.Apd ≥41 mm). Role of the Funder/Sponsor: The Spanish Ministry of Economy and Competitiveness had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
